Johnson & Johnson (JNJ)

130.79
5.40 4.00
NYSE : Health Technology
Prev Close 136.17
Open 133.31
Day Low/High 130.45 / 134.39
52 Wk Low/High 121.00 / 148.99
Volume 7.18M
Avg Volume 7.41M
Exchange NYSE
Shares Outstanding 2.64B
Market Cap 356.74B
EPS 5.70
P/E Ratio 22.42
Div & Yield 3.80 (2.79%)

Latest News

J&J, Morgan Stanley, Coca-Cola and More - Biggest Earnings for This Week

J&J, Morgan Stanley, Coca-Cola and More - Biggest Earnings for This Week

Here's list of key companies reporting earnings the week of October 14, 2019.

Rallying on a Downside Surprise?: Cramer's 'Mad Money' Recap (Thursday 10/17/19)

Rallying on a Downside Surprise?: Cramer's 'Mad Money' Recap (Thursday 10/17/19)

Jim Cramer explains the unexpected: quarterly results are 'not as bad as feared' -- NABAF. It's boosting stocks that, based on the headlines, should really just crumple.

All Mixed Up

Thursday's session was mixed, but we saw some decent statistics such as terrific breadth and more new highs.

Jim Cramer: Here's How You Get a Not as Bad as Feared Quarter

Jim Cramer: Here's How You Get a Not as Bad as Feared Quarter

I have the answer behind the conundrum that forces stocks up that should be going lower.

Video: Jim's Daily Rundown for Thursday

Jim discusses this morning's interview with Larry Kudlow, yesterday's with Marc Benioff, Johnson & Johnson, and Honeywell's earnings.

Jim Cramer: Netflix and CSX Lead the 'NABAF' Earnings Story

Jim Cramer: Netflix and CSX Lead the 'NABAF' Earnings Story

These stocks's earnings were 'not as bad as feared,' and here are some more names that pushed the NABAF narrative.

Stocks End Down as Trade War Fears, Weak Retail Sales Overshadow Strong Earnings

Stocks End Down as Trade War Fears, Weak Retail Sales Overshadow Strong Earnings

Stocks finish down as investors divide their attention between strong third-quarter earnings and concerns over weak U.S. retail sales and the ongoing U.S.-China trade war.

Jim Cramer: The Market Is Lapping Up These Stocks

Jim Cramer: The Market Is Lapping Up These Stocks

There are plenty of senior growth companies that can still move higher.

Johnson & Johnson Gains On Opioid Settlement Reports; Distribution Firms Surge

Johnson & Johnson Gains On Opioid Settlement Reports; Distribution Firms Surge

Johnson & Johnson extended gains Wednesday amid reports it could be close to agreeing a multi-billion dollar settlement with state attorneys general over its role in the nation's opioid crisis.

Dow Futures Slip, Global Stocks Mixed; Brexit Talks, US Earnings Drive Sentiment

Dow Futures Slip, Global Stocks Mixed; Brexit Talks, US Earnings Drive Sentiment

Global stocks traded mixed Wednesday, with modest gains in Asia offset by weaker U.S. equity futures, as investors eyed the final hours of Brexit negotiations between Britain and the EU while awaiting around round of third quarter earnings reports on Wall Street.

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

Netflix, Bank of America, Opioid Settlement, Brexit, MGM- 5 Things You Must Know

U.S. stock futures decline as Wall Street awaits another round of third-quarter earnings reports and global stocks trade mixed as investors monitored Brexit developments; Netflix, IBM and Bank of America report earnings Wednesday; McKesson, AmerisourceBergen and Cardinal Health reportedly are in talks to pay $18 billion to settle thousands of opioid-related lawsuits.

Stocks End Higher on Solid Earnings From JPMorgan Chase, UnitedHealth and J&J

Stocks End Higher on Solid Earnings From JPMorgan Chase, UnitedHealth and J&J

Stocks finish near record highs Tuesday as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson override investors' lingering questions about the fate of U.S.-China trade talks.

Jim Cramer: Here's What We Can Bask in Today

Jim Cramer: Here's What We Can Bask in Today

On days like today you realize how much of this market has been mauled by the bear.

Sectors to Keep an Eye on as Earnings Season Heats Up

Sectors to Keep an Eye on as Earnings Season Heats Up

Here are two and a half sectors to pay attention to during the earnings season. Hint: one has heavy exposure to China.

Johnson & Johnson Reports Third Quarter Top and Bottom Line Beat

This strong beat and raise result should spark renewed buying interest in the stock.

How Goldman Sachs Stock Can Rally to Its Highs on Earnings

How Goldman Sachs Stock Can Rally to Its Highs on Earnings

Goldman Sachs stock is near flat on Tuesday, despite missing on earnings and revenue expectations. Here's how to trade GS stock from here.

J&J Earnings Are Just What's Needed for a Breakout

J&J Earnings Are Just What's Needed for a Breakout

Johnson & Johnson delivered a beat-and-raise quarter, which is just what the doctor ordered for a breakout. Let's look at the charts of JNJ stock.

Buying More AbbVie and Goldman Sachs

ABBV stock is still around our average cost basis price, and with GS we believe there is justification to buy back the remaining 25 shares we previously sold higher.

Banks and Other Early Q3 Reporters Come Out of the Gate

Among the 160 or so reports set for this week, 52 will be from S&P 500 companies and seven are Dow 30 constituents.

Video: AAP Daily Rundown for Tuesday

Jeff fills in for Jim and discusses this morning's earnings from Goldman Sachs, Citigroup, JP Morgan, UnitedHealth Group, and much more!

Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises

Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises

Johnson & Johnson posted stronger-than-expected third quarter earnings Tuesday, and lifted its full-year sales and profit guidance, as pharmaceutical revenues surprised to the upside.

Dow Futures Jump Higher, Global Stocks Gain Ahead of Heavy Q3 Earnings Slate

Dow Futures Jump Higher, Global Stocks Gain Ahead of Heavy Q3 Earnings Slate

Global stocks traded cautiously higher Tuesday, while U.S. equity futures pointed to a firmer open on Wall Street, as investors prepped for a two-day wave of bank earnings that could define the third quarter reporting season while paring risk positions amid lingering questions over the fate trade talks between Washington and Beijing.

Valuation and 2 Names to Watch Into Earnings: Market Recon

Valuation and 2 Names to Watch Into Earnings: Market Recon

Citigroup and Lululemon are on the radar this morning.

JPMorgan Chase, Citigroup, Walmart, General Motors, J&J - 5 Things You Must Know

JPMorgan Chase, Citigroup, Walmart, General Motors, J&J - 5 Things You Must Know

U.S. stock futures rise as investors prep for a two-day wave of bank earnings; Citigroup, JPMorgan Chase, Wells Fargo and Goldman Sachs report earnings Tuesday; the UAW plans a call Thursday to update striking workers on the status of talks with General Motors.

Johnson & Johnson Reports 2019 Third-Quarter Results

Johnson & Johnson Reports 2019 Third-Quarter Results

- Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%*

This Week's Earnings Previews

These 5 companies report between Tuesday and Friday.

Video: AAP Daily Rundown for Monday

Jeff fills in for Jim and discusses this week's earnings of Goldman Sachs, UnitedHealth Group , Abbott Laboratories, and many more!

TheStreet Quant Rating: B (Buy)